These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 37843733)

  • 21. Enhanced Oral Bioavailability of Epalrestat SBE
    Alvi Z; Akhtar M; Mahmood A; Ur-Rahman N; Nazir I; Sadaquat H; Ijaz M; Syed SK; Waqas MK; Wang Y
    Int J Nanomedicine; 2021; 16():8353-8373. PubMed ID: 35002232
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Complexation as an approach to entrap cationic drugs into cationic nanoparticles administered intranasally for Alzheimer's disease management: preparation and detection in rat brain.
    Hanafy AS; Farid RM; ElGamal SS
    Drug Dev Ind Pharm; 2015; 41(12):2055-68. PubMed ID: 26133084
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Therapeutic effect of 5-ASA and hesperidin-loaded chitosan/Eudragit® S100 nanoparticles as a pH-sensitive carrier for local targeted drug delivery in a rat model of ulcerative colitis.
    Abdollahy A; Salehi M; Mahami S; Bernkop-Schnürch A; Vahedi H; Gharravi AM; Mehrabi M
    Int J Pharm; 2024 Mar; 652():123838. PubMed ID: 38266937
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Preparation of Doxorubicin-Loaded Carboxymethyl-β-Cyclodextrin/Chitosan Nanoparticles with Antioxidant, Antitumor Activities and pH-Sensitive Release.
    Mi Y; Zhang J; Tan W; Miao Q; Li Q; Guo Z
    Mar Drugs; 2022 Apr; 20(5):. PubMed ID: 35621929
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Raloxifene/SBE-β-CD Inclusion Complexes Formulated into Nanoparticles with Chitosan to Overcome the Absorption Barrier for Bioavailability Enhancement.
    Wang Z; Li Y
    Pharmaceutics; 2018 Jun; 10(3):. PubMed ID: 29958389
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Co-Delivery of Docetaxel and Berbamine by Chitosan/Sulfobutylether-β-Cyclodextrin Nanoparticles for Enhancing Bioavailability and Anticancer Activities.
    Wu J; Bu X; Dou L; Fang L; Shen Q
    J Biomed Nanotechnol; 2015 Oct; 11(10):1847-57. PubMed ID: 26502647
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Design and evaluation of novel pH-sensitive chitosan nanoparticles for oral insulin delivery.
    Makhlof A; Tozuka Y; Takeuchi H
    Eur J Pharm Sci; 2011 Apr; 42(5):445-51. PubMed ID: 21182939
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Carboxymethyl β-cyclodextrin grafted carboxymethyl chitosan hydrogel-based microparticles for oral insulin delivery.
    Yang Y; Liu Y; Chen S; Cheong KL; Teng B
    Carbohydr Polym; 2020 Oct; 246():116617. PubMed ID: 32747257
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Chitosan/Cyclodextrin Nanospheres for Potential Nose-to-Brain Targeting of Idebenone.
    De Gaetano F; d'Avanzo N; Mancuso A; De Gaetano A; Paladini G; Caridi F; Venuti V; Paolino D; Ventura CA
    Pharmaceuticals (Basel); 2022 Sep; 15(10):. PubMed ID: 36297318
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Preparation and Evaluation of N-Trimethyl Chitosan Nanoparticles of Flurbiprofen for Ocular Delivery.
    Shinde UA; Joshi PN; Jain DD; Singh K
    Curr Eye Res; 2019 May; 44(5):575-582. PubMed ID: 30632402
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A New Insight to Silver Sulfadiazine Antibacterial Dressings: Nanoparticle-Loaded Nanofibers for Controlled Drug Delivery.
    Mutlu-Ağardan NB; Tort S; Aydoğduoğlu Ş; Kıymacı ME
    AAPS PharmSciTech; 2022 Nov; 24(1):8. PubMed ID: 36451066
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Synthesis of β-cyclodextrin modified chitosan-poly(acrylic acid) nanoparticles and use as drug carriers.
    Wang X; Chen C; Huo D; Qian H; Ding Y; Hu Y; Jiang X
    Carbohydr Polym; 2012 Sep; 90(1):361-9. PubMed ID: 24751053
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Oral insulin delivery by carboxymethyl-β-cyclodextrin-grafted chitosan nanoparticles for improving diabetic treatment.
    Song M; Wang H; Chen K; Zhang S; Yu L; Elshazly EH; Ke L; Gong R
    Artif Cells Nanomed Biotechnol; 2018; 46(sup3):S774-S782. PubMed ID: 30280608
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Preparation, characterization and in vitro release study of β-cyclodextrin/chitosan nanoparticles loaded Cinnamomum zeylanicum essential oil.
    Matshetshe KI; Parani S; Manki SM; Oluwafemi OS
    Int J Biol Macromol; 2018 Oct; 118(Pt A):676-682. PubMed ID: 29959997
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Chitosan nanoparticles for intranasal delivery of olmesartan medoxomil: Pharmacokinetic and pharmacodynamic perspectives.
    Hassan RH; Gad HA; El-Din SB; Shaker DS; Ishak RAH
    Int J Pharm; 2022 Nov; 628():122278. PubMed ID: 36243325
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mesalazine/hydroxypropyl-β-cyclodextrin/chitosan nanoparticles with sustained release and enhanced anti-inflammation activity.
    Tang P; Sun Q; Zhao L; Pu H; Yang H; Zhang S; Gan R; Gan N; Li H
    Carbohydr Polym; 2018 Oct; 198():418-425. PubMed ID: 30093018
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Chitosan/cyclodextrin nanoparticles as macromolecular drug delivery system.
    Krauland AH; Alonso MJ
    Int J Pharm; 2007 Aug; 340(1-2):134-42. PubMed ID: 17459620
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cationic cyclodextrin/alginate chitosan nanoflowers as 5-fluorouracil drug delivery system.
    Lakkakula JR; Matshaya T; Krause RW
    Mater Sci Eng C Mater Biol Appl; 2017 Jan; 70(Pt 1):169-177. PubMed ID: 27770878
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Polyglutamic Acid Functionalization of Chitosan Nanoparticles Enhances the Therapeutic Efficacy of Insulin Following Oral Administration.
    Urimi D; Agrawal AK; Kushwah V; Jain S
    AAPS PharmSciTech; 2019 Feb; 20(3):131. PubMed ID: 30815757
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The enzyme-sensitive release of prodigiosin grafted β-cyclodextrin and chitosan magnetic nanoparticles as an anticancer drug delivery system: Synthesis, characterization and cytotoxicity studies.
    Rastegari B; Karbalaei-Heidari HR; Zeinali S; Sheardown H
    Colloids Surf B Biointerfaces; 2017 Oct; 158():589-601. PubMed ID: 28750341
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.